Safety and efficacy of diazepam autoinjector for the management of epilepsy

References

• Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46(4):470-2
   PubMed Web of Science ®Google Scholar
• Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinical definition of epilepsy. Epilepsia 2014;55(4):475-82
   PubMed Web of Science ®Google Scholar
• Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ 2014;28(348):g254
   Google Scholar
• Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the “common” neurologic disorders? Neurology 2007;68:326-37
   PubMed Web of Science ®Google Scholar
• Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17(1):3-23
   PubMed Web of Science ®Google Scholar
• Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41(Suppl 2):S23-30
   PubMedGoogle Scholar
• Pujar SS, Neville BG, Scott RC, Chin RF. Death within 8 years after childhood convulsive status epilepticus: a population-based study. Brain 2011;134:2819-27
   PubMedGoogle Scholar
• Cock HR, Schapira AH. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM 2002;95(4):225-31
   Google Scholar
• Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7
   PubMed Web of Science ®Google Scholar
• Silbergleit R, Lowenstein D, Durkalski V, Conwit R; Neurological Emergency Treatment Trials (NETT) Investigators. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia 2011;52(Suppl 8):45-7
   PubMedGoogle Scholar
• Gottwald MD, Akers LC, Liu PK, et al. Prehospital stability of diazepam and lorazepam. Am J Emerg Med 1999;17(4):333-7
   PubMedGoogle Scholar
• Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600
   PubMed Web of Science ®Google Scholar
• Pellock JM. Safety of Diastat, a rectal gel formulation of diazepam for acute seizure treatment. Drug Saf 2004;27(6):383-92
   Google Scholar
• Cereghino JJ, Cloyd JC, Kuzniecky RI; North American Diastat Study Group. Rectal diazepam gel for treatment of acute repetitive seizures in adults. Arch Neurol 2002;59(12):1915-20
   PubMedGoogle Scholar
• Cereghino JJ. Identification and treatment of acute repetitive seizures in children and adults. Curr Treat Options Neurol 2007;9(4):249-55
   PubMedGoogle Scholar
• Body R, Ijaz M. Best evidence topic report. Buccal midazolam as an alternative to rectal diazepam for prolonged seizures in childhood and adolescence. Emerg Med J 2005;22(5):364-5
   Google Scholar
• Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999;353(9153):623-6
   PubMed Web of Science ®Google Scholar
• McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366:205-10
   PubMed Web of Science ®Google Scholar
• Baysun S, Aydin OF, Atmaca E, Gurer YK. A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures. Clin Pediatr (Phila) 2005;44:771-6
   PubMed Web of Science ®Google Scholar
• Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics 2005;121:e58-64
   Google Scholar
• Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain Dev 2009;31(10):744-9
   PubMed Web of Science ®Google Scholar
• Ashrafi MR, Khosroshahi N, Karimi P, et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol 2010;14(5):434-8
   PubMed Web of Science ®Google Scholar
• Nakken KO, Lossius MI. Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus. Acta Neurol Scand 2011;124:99-103
   PubMed Web of Science ®Google Scholar
• Garnock-Jones KP. Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures. Paediatr Drugs 2012;14(4):251-61
   PubMedGoogle Scholar
• Scott LJ, Lyseng-Williamson KA, Garnock-Jones KP. Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizures. CNS Drugs 2012;26(10):893-7
   Google Scholar
• European Medicines Agency. Buccolam 2.5 mg oromucosal solution: summary of product characteristics. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002267/WC500112310.pdf
   Google Scholar
• NICE clinical guideline 137. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Issued: January 2012 Available from: guidance.nice.org.uk/cg137 [Last modified December 2013]
   Google Scholar
• Fişgin T, Gurer Y, Teziç T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol 2002;17(2):123-6
   PubMed Web of Science ®Google Scholar
• Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 2004;5(2):253-5
   PubMed Web of Science ®Google Scholar
• Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol 2006;34(5):355-9
   PubMed Web of Science ®Google Scholar
• Holsti M, Sill BL, Firth SD, et al. Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care 2007;23(3):148-53
   PubMedGoogle Scholar
• Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med 2010;164(8):747-53
   PubMedGoogle Scholar
• de Haan GJ, van der Geest P, Doelman G, et al. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 2010;51(3):478-82
   PubMed Web of Science ®Google Scholar
• Ulgey A, Aksu R, Bicer C. Nasal and buccal treatment of midazolam in epileptic seizures in pediatrics. Clin Med Insights Pediatr 2012;6:51-60
   Google Scholar
• Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol 2012;260(2):470-4
   Google Scholar
• Humphries LK, Eiland LS. Treatment of acute seizures: is intranasal midazolam a viable option? J Pediatr Pharmacol Ther 2013;18(2):79-87
   Google Scholar
• McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med 2010;17(6):575-82
   PubMed Web of Science ®Google Scholar
• Abou-Khalil B, Wheless J, Rogin J, et al. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia 2013;54(11):1968-76
   PubMed Web of Science ®Google Scholar
• Ivaturi V, Kriel R, Brundage R, et al. Bioavailability of intranasal vs. rectal diazepam. Epilepsy Res 2013;103(2-3):254-61
   PubMed Web of Science ®Google Scholar
• Agarwal SK, Kriel RL, Brundage RC, et al. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Epilepsy Res 2013;105(3):362-7
   PubMed Web of Science ®Google Scholar
• Mula M. The safety and tolerability of intranasal midazolam in epilepsy. Expert Rev Neurother 2014;14(7):735-40
   PubMed Web of Science ®Google Scholar
• McDonough JHJr, Shih TM. Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 1993;17(2):203-15
   Google Scholar
• Shih T, McDonough JHJr, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999;6(2):86-96
   PubMed Web of Science ®Google Scholar
• Diazepam injection [U.S. Army Medical Research and Development Command (MCMR-RCQHR)]. Available from: http://www.fda.gov/ohrms/dockets/dailys/01/Nov01/113001/01p_0542/VOL%200001/cp00001_02_Attachment_1.pdf
   Google Scholar
• Lehmann C, Wannarka GL. Bioavailability and dose proportionality of intramuscular diazepam administered by autoinjector. J Clin Pharmacol 2008;48(4):436-44
   Google Scholar
• Lamson MJ, Sitki-Green D, Wannarka GL, et al. Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study. Clin Drug Investig 2011;31(8):585-97
   PubMed Web of Science ®Google Scholar
• Garnett WR, Barr WH, Edinboro LE, et al. Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: a pharmacokinetic comparison. Epilepsy Res 2011;93(1):11-16
   PubMed Web of Science ®Google Scholar
• Rogin J, Wheless J, Abou-Khalil B, et al. Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures. Epilepsia 2014;55(9):1444-51
   PubMed Web of Science ®Google Scholar
• Efficacy and Safety of Vanquix for the Management of Selected, Refractory, Patients With Epilepsy Who Require Intermittent Caregiver Medical Intervention to Control Episodes of Acute Repetitive Seizures. Available from: http://clinicaltrials.gov/ct2/show/record/NCT00319501
   Google Scholar